Click to view timeline
Timeline
Projects
Patents
Former Teams
Publications
Download-
2023Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants., iScience 2023 Feb; (): 106124.
-
2019A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice, Front. Immunol. 2019 Jun;10 (1424).
-
2018Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans, Viruses 2018 09;10(9).
-
2018Host genetic control of mosquito-borne Flavivirus infections., Mamm Genome 2018 08; 29(7-8): 384-407.
-
2018Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development, Int J Environ Res Public Health 2018 02;15(2).
-
2009Maturation of mouse NK cells is a 4-stage developmental program, Blood 2009 May;113(22):5488-96.
-
2007Stromal-cell regulation of natural killer cell differentiation, J. Mol. Med. 2007 Oct;85(10):1047-56.
-
2006Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases, Nat. Immunol. 2006 Jul;7(7):747-54.
-
2001Identification of committed NK cell progenitors in adult murine bone marrow, Eur. J. Immunol. 2001 Jun;31(6):1900-9.
-
2000Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC, Immunity 2000 Jul;13(1):143-53.
-
+View full list of publications